These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 20099165

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Regulation of donor T cells in the tolerant rats to graft-versus-host disease by FTY720 following small bowel transplantation.
    Song J, Ito T, Matsuda C, Tanemura M, Nishida T, Nozawa M, Sawa Y.
    Transplant Proc; 2006 Dec; 38(10):3181-3. PubMed ID: 17175216
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of donor-derived T cells trafficking into target organs by FTY720 during acute graft-versus-host disease in small bowel transplantation.
    Song J, Ito T, Matsuda C, Miao G, Tanemura M, Nishida T, Nozawa M, Matsuda H, Sawa Y.
    Clin Exp Immunol; 2006 Oct; 146(1):85-92. PubMed ID: 16968402
    [Abstract] [Full Text] [Related]

  • 4. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T, Kiyochi H, Honda K, Kobayashi N.
    Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prevention of GVHD and graft rejection by a new S1P receptor agonist, W-061, in rat small bowel transplantation.
    Song J, Hagiya H, Kurata H, Mizuno H, Ito T.
    Transpl Immunol; 2012 Mar; 26(2-3):163-70. PubMed ID: 22210496
    [Abstract] [Full Text] [Related]

  • 8. FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells.
    Kimura T, Hasegawa T, Nakai H, Azuma T, Usui N, Sasaki T, Okada A.
    Transplantation; 2003 May 15; 75(9):1469-74. PubMed ID: 12792499
    [Abstract] [Full Text] [Related]

  • 9. FTY720 enhances the activation-induced apoptosis of donor T cells and modulates graft-versus-host disease.
    Hashimoto D, Asakura S, Matsuoka K, Sakoda Y, Koyama M, Aoyama K, Tanimoto M, Teshima T.
    Eur J Immunol; 2007 Jan 15; 37(1):271-81. PubMed ID: 17154260
    [Abstract] [Full Text] [Related]

  • 10. Evidence that FTY720 induces rat thymocyte apoptosis.
    Isoyama N, Takai K, Tsuchida M, Matsumura M, Naito K.
    Transpl Immunol; 2006 Apr 15; 15(4):265-71. PubMed ID: 16635748
    [Abstract] [Full Text] [Related]

  • 11. Control of intestinal allograft rejection by FTY720 and costimulation blockade.
    Yan S, Rodriguez-Barbosa JI, Pabst O, Beckmann JH, Brinkmann V, Förster R, Hoffmann MW.
    Transplant Proc; 2005 Apr 15; 37(1):114-5. PubMed ID: 15808565
    [Abstract] [Full Text] [Related]

  • 12. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T, Van Damme B, Rutgeerts O, Waer M, Pirenne J.
    Transplantation; 2003 Apr 15; 75(7):945-52. PubMed ID: 12698078
    [Abstract] [Full Text] [Related]

  • 13. Long-term effect of FTY720 on lymphocyte count and islet allograft survival in mice.
    Liu L, Wang C, He X, Shang W, Bi Y, Wang D.
    Microsurgery; 2007 Apr 15; 27(4):300-4. PubMed ID: 17477424
    [Abstract] [Full Text] [Related]

  • 14. Effect of FTY720 in rat small bowel transplantation: expression of mucosal addressin cell adhesion molecule-1.
    Sugito K, Koshinaga T, Inoue M, Ikeda T, Hagiwara N, Fukuzawa M.
    Transplant Proc; 2005 Dec 15; 37(10):4472-4. PubMed ID: 16387148
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing.
    Chiba K, Yanagawa Y, Masubuchi Y, Kataoka H, Kawaguchi T, Ohtsuki M, Hoshino Y.
    J Immunol; 1998 May 15; 160(10):5037-44. PubMed ID: 9590253
    [Abstract] [Full Text] [Related]

  • 17. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
    Yanagawa Y, Sugahara K, Kataoka H, Kawaguchi T, Masubuchi Y, Chiba K.
    J Immunol; 1998 Jun 01; 160(11):5493-9. PubMed ID: 9605152
    [Abstract] [Full Text] [Related]

  • 18. Reduction of ischemia-reperfusion injury in the rat kidney by FTY720, a synthetic derivative of sphingosine.
    Delbridge MS, Shrestha BM, Raftery AT, El Nahas AM, Haylor JL.
    Transplantation; 2007 Jul 27; 84(2):187-95. PubMed ID: 17667810
    [Abstract] [Full Text] [Related]

  • 19. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
    Chiba K.
    Pharmacol Ther; 2005 Dec 27; 108(3):308-19. PubMed ID: 15951022
    [Abstract] [Full Text] [Related]

  • 20. FTY720 treatment prolongs skin graft survival in a completely incompatible strain combination.
    Lima RS, Nogueira-Martins MF, Silva HT, Pestana JO, Bueno V.
    Transplant Proc; 2004 May 27; 36(4):1015-7. PubMed ID: 15194353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.